Teva Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- US stock futures down as Middle East strikes fuel inflation anxiety
- Oil rises over 3% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
Teva Pharma (TEVA) Reports In-Line Q1 EPS, Reaffirms Outlook
May 11, 2017 7:03 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.7 billion.
Dr. Peterburg continued, Looking forward to the rest of 2017, we are reaffirming our full-year... More
